Edwards Lifesciences CSCS Manual De Instrucciones página 3

6. Tightly wrap the cuff around the finger and ensure that
the correct size cuff has been chosen by checking that
the outer edge lines up within the green area of the
cuff when wrapped tightly (Fig 4).
NOTE: Do not rotate the finger cuff after application
(Fig 5).
7. Connect the finger cuff to the pressure controller (Fig 6).
Apply second Finger Cuff
It is recommended to apply an additional finger cuff
to a second finger on the same hand when continuous
monitoring is expected to last longer than 8 hours,
or to increase patient comfort.
8. Repeat Steps 1-7 to apply the second finger cuff.
NOTE: When only a single finger cuff is used, it is
recommended that the second cuff connector opening in
the pressure controller is closed with the appropriate cuff
connector cap (PC2CCC) to prevent ingress by liquid and dirt
(Fig 6).
Cleaning instructions
The ClearSight finger cuff is designed for single patient use
only. Do not attempt to clean and reuse the ClearSight finger
cuff on more than a single patient.
Accessories
Model
Description
Number
ClearSight Finger Cuff Small
CSCS
(Multi Pack of 5)
ClearSight Finger Cuff Medium
CSCM
(Multi Pack of 5)
ClearSight Finger Cuff Large
CSCL
(Multi Pack of 5)
Pressure Controller Cuff Connector Caps
PC2CCC
(Multi Pack of 25)
Warranty
The ClearSight finger cuff is for single patient use only.
The ClearSight finger cuffs are warranted at time of delivery
to the end user only. The ClearSight finger cuff is a non-
serviceable part.
Technical Assistance
For technical assistance, please call Edwards Technical
Support at the following telephone numbers:
Inside the U.S. and Canada
(24 hours): . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800.822.9837
Outside the U.S. and Canada
(24 hours): . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 949.250.2222
In the UK: . . . . . . . . . . . . . . . . . . . . . . 0870 606 2040 - Option 4
In Ireland: . . . . . . . . . . . . . . . . . . . . . . . . . . 01 8211012 Option 4
This document is subject to change without prior notice.
Refer to the latest version of the EV1000 clinical platform
NI or HemoSphere advanced monitoring platform NI
operator's Manual for more additional information.
Users and/or patients should report any serious incidents
to the manufacturer and the Competent Authority of the
Member State in which the user and/or patient is established.
3